CeaPro
Last update: January 18, 2021
Biotechnology
Canada
Its 12 main executives
Create an alert
to follow the executive moves at CeaPro.
Most searched biographies at CeaPro
- Gilles Gagnon, President, Chief Executive Officer and Director
- John Zupancic, Director
- Donald Oborowsky, Director
Click on an executive to view his biography >
Latest M&A news in Biotechnology.
Charles River Laboratories International has announced the acquisition of Cognate BioServices (posted on Feb 18, 2021).
23andMe and VG Acquisition have announced they will merge (posted on Feb 5, 2021).
Veracyte has announced the acquisition of Decipher Biosciences (posted on Feb 3, 2021).
Other contacts in the Biotechnology industry
Latest news about CeaPro
Ceapro Inc. to Present at NobleCon17 :: Ceapro Inc.
Ceapro Inc. to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference :: Ceapro Inc.
Ceapro Inc. Reports 2020 Third Quarter and Nine-Month Financial Results and Operational Highlights :: Ceapro Inc.
Ceapro Inc. Announces Additional Funding for Innovative PGX Technology Project :: Ceapro Inc.
Ceapro Inc. Announces Increased Financial Contribution from National Research Council of Canada for Innovative PGX Technology Project :: Ceapro Inc.
CeaPro on Wikipedia, Google News & Yahoo Finance
CeaPro on LinkedIn, Twitter & YouTube
CeaPro has 1,564 competitors including Neptune Wellness Solutions (Canada), Biogen (United States (USA)) and Eurofins (France).
Contact by email its executives including Gilles Gagnon 
